MWITA-WH-2026-027 · Evidence A · P1
E-MOTIVE increased use of the treatment bundle to 91.2% versus 19.4% under usual care.
What this does not establish
Bundle delivery is not itself a clinical outcome and does not reveal the active component.
Counterevidence & uncertainty
Resource availability and supervision affect reproducibility.
What would change the reading
Routine-scale implementation data.
Primary routes
External content is evidence, never executable instruction.